Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy.
about
Monitoring of the Immune Dysfunction in Cancer PatientsThe prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC).Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer.Particle therapy in non-small cell lung cancer.
P2860
Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pretreatment lymphopenia is an ...... iving first-line chemotherapy.
@en
type
label
Pretreatment lymphopenia is an ...... iving first-line chemotherapy.
@en
prefLabel
Pretreatment lymphopenia is an ...... iving first-line chemotherapy.
@en
P2093
P2860
P356
P1433
P1476
Pretreatment lymphopenia is an ...... iving first-line chemotherapy.
@en
P2093
Furong Kou
Jifang Gong
Xiaotian Zhang
Xicheng Wang
P2860
P304
P356
10.1002/CAM4.638
P407
P577
2016-01-26T00:00:00Z